Crowdsourcing to better forecast drug approvals
Researchers launched an in-house Data Science and Artificial Intelligence (DSAI) challenge to beat MIT’s machine-learning models for predicting clinical trial outcomes. The results are now available.
Researchers launched an in-house Data Science and Artificial Intelligence (DSAI) challenge to beat MIT’s machine-learning models for predicting clinical trial outcomes. The results are now available.
MIT Sloan and CSAIL researchers apply artificial intelligence techniques to one of the largest datasets of clinical trial outcomes to handicap the drug and device approval process
Machine learning is a powerful form of artificial intelligence that is affecting every industry. Here’s what you need to know about its potential and limitations and how it’s being used.
Over 1,300 Sloanies and their guests returned to campus in early June to attend MIT Sloan Reunion 2023.